Fructooligosaccharides Global Market Report 2024

The fructooligosaccharides market size has grown strongly in recent years. It will grow from $2.72 billion in 2023 to $2.95 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The growth witnessed in the historic period can be ascribed to several factors, including heightened interest in prebiotics, expanded utilization of FOS in infant formulations, increased need for diabetic-friendly sweeteners, a surge in demand for functional foods, and a rise in demand for animal feed.

The fructooligosaccharides market size is expected to see strong growth in the next few years. It will grow to $4.1 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. In the forecast period, growth is expected to be driven by escalating demand for low-calorie sweeteners, a rise in the consumption of functional foods, heightened awareness regarding gut health, preferences of health-conscious consumers, demographic shifts such as an aging population, and changes in lifestyle habits. Notable trends anticipated in the forecast period include the increasing demand for natural ingredients, a growing preference for low-calorie foods, the introduction of cost-effective production methods, a focus on research and development initiatives, and the development of innovative product formulations.

The expected rise in obesity rates is forecasted to drive the growth of the fructooligosaccharides market in the future. Obesity, characterized by excessive body fat accumulation and detrimental health effects, is attributed to the widespread availability of calorie-dense, fatty, and sugary foods, sedentary lifestyles, and decreased physical activity. Fructooligosaccharides (FOS) serve as dietary supplements or functional ingredients in foods, potentially aiding in obesity management. They enhance lipid and glucose metabolism, potentially improving energy utilization and weight control. For example, in March 2023, the World Heart Foundation reported that approximately 2.3 billion adults and children worldwide are obese or overweight, with projections reaching 2.7 billion by 2025. Consequently, escalating obesity concerns propel the fructooligosaccharides market forward.

Leading companies in the fructooligosaccharides market are expanding their production capabilities to meet rising demand and capitalize on market growth opportunities. Investments in fructooligosaccharide production plants aim to increase the production capacity of GOFOS, a soluble short-chain fructooligosaccharide (sc-FOS) prebiotic fiber. For instance, in January 2022, Galam, an Israel-based fructooligosaccharide manufacturer, invested $30 million in expanding its production of prebiotic GOFOS. This expansion supports the increasing demand for GOFOS, utilized in various food applications such as cereals, energy bars, dairy and non-dairy products, confectionery, bakery, and chocolate. GOFOS is recognized for its prebiotic properties, fostering the growth and maintenance of beneficial gut bacteria and promoting digestive and immune health.

In June 2022, Tate & Lyle PLC, a UK-based provider of food and beverage ingredients and solutions, acquired Quantum Hi-Tech Biological Co. Ltd. for an undisclosed sum. This acquisition enables Tate & Lyle PLC to enhance its fiber solutions portfolio across various categories, including dairy, beverages, bakery, and nutrition, to meet growing consumer interest in gut health. Quantum Hi-Tech Biological Co. Ltd., based in China, specializes in manufacturing prebiotic ingredients such as fructooligosaccharides (FOS) and galactooligosaccharides (GOS).

Major companies operating in the fructooligosaccharides market are Saintroy Lifescience, Cargill Inc., CJ Group, Brenntag SE, Royal FrieslandCampina NV, Südzucker AG, Ingredion Incorporated, Meiji Holdings Co. Ltd, Tereos Group, Nissin Sugar Co. Ltd., Yakult Pharmaceutical Industry Co. Ltd., Sigma-Aldrich Corporation, Tate & Lyle PLC, Baolingbao Biology Co. Ltd., Sensus, Beneo GmbH, Jarrow Formulas Inc., Quantum Hi-Tech (China) Biological Co. Ltd., Galam Ltd., Cosucra Co., Dextra Laboratories Limited, AIDP Inc., GTC Nutrition, Beghin-Meiji SA, S.A. Pharmachem Pvt. Ltd.

North America was the largest region in the fructooligosaccharides market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fructooligosaccharides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fructooligosaccharides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Fructooligosaccharides (FOS) represent a category of carbohydrates made up of short fructose chains, naturally occurring in a variety of plants such as blue agave, chicory root, and bananas. They are indigestible, offering a low-calorie, sweet substitute for sugar, and have been associated with several health advantages, including prebiotic effects, enhanced mineral absorption, and reduced cholesterol levels.

The primary sources of fructooligosaccharides are chicory and sucrose. Chicory, a plant type, serves as the basis for fructooligosaccharide (FOS) production through the enzymatic conversion of sucrose. These come in different forms such as powder and liquid, applied across various sectors including food and beverages, animal feed, dietary supplements, infant formula, pharmaceuticals, and others.

The fructooligosaccharides market research report is one of a series of new reports that provides fructooligosaccharides market statistics, including fructooligosaccharides industry global market size, regional shares, competitors with a fructooligosaccharides market share, detailed fructooligosaccharides market segments, market trends, and opportunities, and any further data you may need to thrive in the fructooligosaccharides industry. This fructooligosaccharides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fructooligosaccharides market consists of sales of Inulin-derived fructooligosaccharides, Levan-type fructooligosaccharides, Neosugar, and Synthesized fructooligosaccharides. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.